Keywords: لنفوم کیناز Anaplastic (ALK); Anaplastic lymphoma kinase (ALK); NSCLC; Thrombosis; Venous thromboembolism;
مقالات ISI لنفوم کیناز Anaplastic (ALK) (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لنفوم کیناز Anaplastic (ALK); Anaplastic lymphoma kinase (ALK); Driver oncogene; Epidermal growth factor receptor (EGFR); KRAS; Non–small-cell lung cancer; NRAS; Pemetrexed; ROS1
PD-L1 expression in lung adenocarcinoma harboring EGFR mutations or ALK rearrangements
Keywords: لنفوم کیناز Anaplastic (ALK); Programmed cell death-ligand 1 (PD-L1); Immunohistochemistry (IHC); Epidermal growth factor receptor (EGFR); Anaplastic lymphoma kinase (ALK); 22C3 pharmDx;
Anaplastic lymphoma kinase protein positive diffuse large B cell lymphoma; A developing world experience
Keywords: لنفوم کیناز Anaplastic (ALK); Anaplastic lymphoma kinase (ALK); Diffuse large B-cell lymphoma (DLBCL); Developing country;
W'ALK' Into the Next Stage
Keywords: لنفوم کیناز Anaplastic (ALK); Anaplastic lymphoma kinase (ALK); Antiangiogenic therapy; Cytotoxic chemotherapy; Immune checkpoint therapy; Sequential therapy with ALK inhibitors;
Replacing the terminal piperidine in ceritinib with aliphatic amines confers activities against crizotinib-resistant mutants including G1202R
Keywords: لنفوم کیناز Anaplastic (ALK); Anaplastic lymphoma kinase (ALK); Non-small cell lung cancer (NSCLC); Ceritinib; Crizotinib-resistant; G1202R;
ALK-FISH borderline cases in non-small cell lung cancer: Implications for diagnostics and clinical decision making
Keywords: لنفوم کیناز Anaplastic (ALK); ADC; adenocarcinoma; ADSC; adenosquamous carcinoma; ALK; anaplastic lymphoma kinase; BL; borderline; CNG; copy number gain; EMA; European Medicines Agency; FDA; Food and Drug Administration; FISH; fluorescence in-situ hybridization; FS; fused signals; FN;
Adjuvant therapy for EGFR mutant and ALK positive NSCLC: Current data and future prospects
Keywords: لنفوم کیناز Anaplastic (ALK); Non-small cell lung cancer (NSCLC); Anaplastic lymphoma kinase (ALK); Epidermal growth factor receptor (EGFR); Adjuvant; Tyrosine kinase inhibitors (TKI);
Discovery of 7-azaindole based anaplastic lymphoma kinase (ALK) inhibitors: Wild type and mutant (L1196M) active compounds with unique binding mode
Keywords: لنفوم کیناز Anaplastic (ALK); PGSYBTKGCJXUAV-UHFFFAOYSA-N; LRWNZUVVRSBHQU-UHFFFAOYSA-N; JJYRLIVLBDHFEU-UHFFFAOYSA-N; FADONZKXBUVWLH-UHFFFAOYSA-N; ATZJNUYRMAFPBF-UHFFFAOYSA-N; FPQUAATUWBOAGG-UHFFFAOYSA-N; SDWMCZUOCJDBOJ-UHFFFAOYSA-N; KNRKBZCJMLVHPB-UHFFFAOYSA-N; ZHUGMFFQPPOJNL-UHFFFAOY
Extra copies of ALK gene locus is a recurrent genetic aberration and favorable prognostic factor in both ALK-positive and ALK-negative anaplastic large cell lymphomas
Keywords: لنفوم کیناز Anaplastic (ALK); Anaplastic large cell lymphoma (ALCL); Anaplastic lymphoma kinase (ALK); Molecular genetics; Fluorescence in situ hybridization (FISH)
Synthesis of an aryloxy oxo pyrimidinone library that displays ALK-selective inhibition
Keywords: لنفوم کیناز Anaplastic (ALK); Anaplastic lymphoma kinase (ALK); Kinase inhibitor; Small library synthesis
ALK-positive extramedullary plasmacytoma with expression of the CLTC-ALK fusion transcript
Keywords: لنفوم کیناز Anaplastic (ALK); Extramedullary plasmacytoma; Anaplastic lymphoma kinase (ALK); Fusion transcript
Anaplastic large-cell lymphoma
Keywords: لنفوم کیناز Anaplastic (ALK); Anaplastic large-cell lymphoma (ALCL); Peripheral T-cell lymphoma (PTCL); Phenotype; Immunohistochemistry; Molecular biology; Targeted therapy; Anaplastic lymphoma kinase (ALK); Chimeric fusion proteins; Signaling pathways
Pleiotrophin induces neurite outgrowth and up-regulates growth-associated protein (GAP)-43 mRNA through the ALK/GSK3β/β-catenin signaling in developing mouse neurons
Keywords: لنفوم کیناز Anaplastic (ALK); Pleiotrophin (PTN); Embryonic mice; Whole mount in situ hybridization; Wnt signaling; Growth-associated protein (GAP)-43; Explant culture; Neurite outgrowth; Anaplastic lymphoma kinase (ALK);
TPM3-ALK expression induces changes in cytoskeleton organisation and confers higher metastatic capacities than other ALK fusion proteins
Keywords: لنفوم کیناز Anaplastic (ALK); Anaplastic lymphoma kinase (ALK); Anaplastic large cell lymphomas (ALCL); Inflammatory myofibroblastic tumours (IMT); X-ALK variants; Experimental lung metastasis; Actin cytoskeleton